First DataBank, Inc.
(FDB), currently owned by Hearst Corporation
, is a publisher of pharmaceutical industry
market information and information technology
. The firm, headquartered in South San Francisco, California
, is best known for its controversial drug pricing surveys of the McKesson Corporation
, a drug wholesaler
, to determine benchmarks
for what drug retailers in the United States
are charged by wholesalers. First DataBank is the top publisher of pharmaceutical market surveys
, which in turn are used by insurers
, state health programs and other drug buyers for the purpose of negotiating reimbursement rates paid to pharmacies and other providers.
First DataBank touts itself as "the leading provider of context-relevant, integrated drug database products." The firm creates and maintains widely used drug database products, software for drug database integration, and drug reference products. The firm has partnered with other developers of drug information systems to make drug data useful for a wide range of drug delivery system users. The firm's software supports pharmacy
management, drug pricing analysis, medical insurance
claims processing computerized physician order entry (CPOE), electronic health records
(EHR), electronic medical records (EMR), electronic prescribing
(e-Prescribing) and electronic medication administration records (EMAR).
First DataBank influences the incidence of medication errors and adverse events
associated with... Read More